Skip to main content
Springer logoLink to Springer
. 2015 Feb 15;19(8):2101–2114. doi: 10.1007/s00784-015-1407-6

A pragmatic approach to infants with Robin sequence: a retrospective cohort study and presence of a treatment algorithm

Emma C Paes 1,5,, Daan P F van Nunen 1, Lucienne Speleman 2, Marvick S M Muradin 3, Bram Smarius 1, Moshe Kon 1, Aebele B Mink van der Molen 1, Titia L E M Niers 4, Esther S Veldhoen 4, Corstiaan C Breugem 1
PMCID: PMC4592702  PMID: 25680705

Abstract

Objectives

Initial approaches to and treatments of infants with Robin sequence (RS) is diverse and inconsistent. The care of these sometimes critically ill infants involves many different medical specialties, which can make the decision process complex and difficult. To optimize the care of infants with RS, we present our institution’s approach and a review of the current literature.

Material and methods

A retrospective cohort study was conducted among 75 infants diagnosed with RS and managed at our institution in the 1996–2012 period. Additionally, the conducted treatment regimen in this paper was discussed with recent literature describing the approach of infants with RS.

Results

Forty-four infants (59 %) were found to have been treated conservatively. A significant larger proportion of nonisolated RS infants than isolated RS infants needed surgical intervention (53 vs. 25 %, p = .014). A mandibular distraction was conducted in 24 % (n = 18) of cases, a tracheotomy in 9 % (n = 7), and a tongue–lip adhesion in 8 % (n = 6). Seventy-seven percent of all infants had received temporary nasogastric tube feeding. The literature review of 31 studies showed that initial examinations and the indications to perform a surgical intervention varied and were often not clearly described.

Conclusions

RS is a heterogenic group with a wide spectrum of associated anomalies. As a result, the decisional process is challenging, and a multidisciplinary approach to treatment is desirable. Current treatment options in literature vary, and a more uniform approach is recommended.

Clinical Relevance

We provide a comprehensive and pragmatic approach to the analysis and treatment of infants with RS, which could serve as useful guidance in other clinics.

Keywords: Pierre Robin, Mandibular distraction, Tracheotomy, Tongue–lip adhesion, Approach, Treatment, Multidisciplinary team

Introduction

Mandibular micrognathia, glossoptosis with subsequent airway obstruction, is the original triad of symptoms described by Pierre Robin in 1923 [1]. By 1934, the frequent association of a cleft palate was noted by him [2]. These features combined are currently known as Robin sequence (RS). RS may be an isolated condition, but an associated syndrome is present in about 45–80 % of cases [3]. Reported incidences are estimated to be 1:8000 to 1: 14000 births [46]. Symptoms of the condition include varying degrees of upper airway obstruction (UAO) and feeding problems, leading to failure to thrive [7, 8]. Mortality rates vary from 0 to 26 % and are most usually caused by severe UAO leading to obstructive apnea and secondary cardiac problems [8].

Infants born with RS have been treated with numerous different methods [9]. Most airway management strategies initiate treatment with positional change [7]. With an inadequate response, nonsurgical interventions, such as the use of a nasopharyngeal airway [10, 11] or a palatal plate [1215], are commonly pursued. Still, in some cases, there can be more severe respiratory obstruction or failure to thrive, necessitating some other form of intervention [16]. This decision-making process can be challenging for caregivers. To date, many authors have described their preferred surgical techniques, such as tongue–lip adhesion (TLA) [17, 18], tracheotomy [19, 20], subperiosteal release of the floor of the mouth [21, 22], or mandibular distraction osteogenesis (MDO) [23, 24].

Currently, guidelines are lacking, and there is a paucity and discrepancy of information in the medical literature on how specific decisions are made. The rationale for the choice of a specific approach is often not or only scantily addressed. It is known that physicians often utilize a treatment method that was learned during their residency period and often continue with this approach [25]. Furthermore, the surgeon’s preference varies between different specialties [25]. Especially in the treatment regimen of this heterogenic disorder, were a multidisciplinary approach is inevitable, all of this may lead to unnecessary interventions and a potential delay in definitive treatment [7, 26].

The objective of this study is to present a treatment algorithm based on our experience of airway management in infants with RS. The rationale of specific decisions will be covered. This will provide a comprehensive guidance for a designated treatment strategy and contributes in optimizing the care of infants with RS.

Material and methods

All infants <1 year old diagnosed with RS, who have been treated at the Wilhelmina Children’s Hospital Utrecht, The Netherlands, over 16 years (1996–2012), were included in this retrospective cohort study. Ethics committee approval was obtained. RS was defined as signs of airway obstruction and presence of micrognathia. Information about duration of admission and treatment outcome with a follow-up of at least 1 year was extracted from medical records. Moreover, demographic characteristics, performed diagnostics, interventions, and treatment approach were critically analyzed. A subdivision between the nonisolated RS infants (i.e., diagnosis of an additional syndrome related to RS or of other associated anomalies or chromosomal defects not directly related to the features of RS) and isolated RS infants (i.e., only the features of RS without any additional anomaly) was made. Independent samples t test and Mann–Whitney U test were performed (IBM SPSS Statistics 20.0, IBM Inc., New York, USA).

Subsequently, a literature search to find existing algorithms covering the approach to infants with RS was performed. The search was performed in January 2014 without time limits. Similar keywords were used in the Embase, Medline, CINAHL, Cochrane Library, and Google Scholar databases [“(pierre) robin syndrome/sequence” and “algorithm(s),” “approach,” “(airway) management,” “intervention,” “regimen,” or “treatment”). Only articles that included a clear description of the patient group, performed examinations, decisional factors, and performed interventions were included. Moreover, concise, state-of-the-art reviews suggesting a treatment approach were included. The bibliographies of the selected studies were hand-searched for any additional articles. The search and inclusion process was performed by two authors (E.P. and B.S.).

Finally, the pragmatic approach from our institution is presented in a schematic way.

Results

Retrospective cohort analyses

From 1996 to 2012, 75 infants diagnosed with RS were treated in our institution. Baseline characteristics are summarized in Table 1. Mean follow-up was 7.4 years (range, 1–17). Fifty-two percent (n = 39) were female. Seventy-two patients (97 %) had a cleft palate. The minority of cases (43 %, n = 32) had an isolated form of RS. In one third of the cohort (31 %, n = 23), an associated syndrome was present, Stickler (n = 11, 48 %) being the most common. In a quarter (26 %, n = 20), additional anomalies or chromosomal defects were identified, which were not directly related to a syndrome associated with the features of RS.

Table 1.

Baseline characteristics of infants with RS patients treated in the Wilhelmina Children’s Hospital 1996–2012

Patients Number of patients (%) Female Male Median age of presentation in days (IQR) Gestational age in days Mean birth weight in grams (SD) Presence of CP (%) CP typeb (%)
Isolated RS 32 (43) 20 12 10.0 (5–17.75) 275(median), 270(p25), 282 (p75) 3135 (789) 97

I (0); II (16); III (58);

IV (26)

Nonisolated RS 43 (57) 19 24 8.0 (1.25–32.75) 277(median), 273 (p25), 282 (p75) 3237 (553) 98 I (3); II (24); III (56); IV (17)
Syndromic RS 23 10 13 7.5 (1–17.75) 279 (median), 273 (p25), 281 (p75) 3314 (512) 100 I (4); II (13); III (61); IV (22)
Stickler syndrome 11
Treacher Collins syndrome 2
Spondyloepiphyseal dysplasia 2
4q deletion syndrome 1
Van der Woude syndrome 1
Osteopathia striata with cranial sclerosis 1
EEC syndromea 1
Goldberg–Shprintzen syndrome 1
Yunis–Varon syndrome 1
Auriculo–Condylar syndrome 1
Hemifacial microsomia 1
RS with other associated anomalies or chromosomal defects 20 9 11 10.5 (2–62.75) 275 (median), 272 (p25), 282 (p75) 3149 (597) 95 I (0); II (37); III (53); IV (10)

RS Robin sequence, SD standard deviation, CP cleft palate, IQR interquartile range

aEEC syndrome, ectrodactyly–ectodermal dysplasia–cleft syndrome

bCP type: I, submucous cleft or bifid uvula; II, soft palate; III, soft palate and segment of the hard palate; IV, soft palate and hard palate up to incisive foramen

The majority (59 %, n = 44) of the infants admitted to our hospital could be successfully managed conservatively (Table 2). This consisted of side/prone positioning, temporary supplemental oxygen or usage of continuous positive airway pressure (CPAP), a mayotube or nasopharyngeal airway (NPA) (Fig. 1). In 41 % (n = 31), a surgical intervention was pursued, at a mean age of 50 days (SD, 55). Until 2006, this consisted of TLA whenever possible. If TLA failed, or there was a (sub)glottic pathology, a tracheotomy was performed. Since 2006, the primary surgical intervention for UAO caused by a supraglottic obstruction is MDO. During the study period, in more than half of the surgically treated cases (58 %, n = 18), MDO was pursued; in 19 % (n = 6) TLA and in 23 % (n = 7), a tracheotomy. Average duration until decannulation after a tracheotomy was 13.4 months (range, 4.1–36.5). More than half of the nonisolated RS infants, compared to only a quarter of the isolated RS, infants needed surgical intervention (53 vs. 25 %, p = .014) (Table 2). Moreover, mean duration of admission was significantly shorter in the isolated group than in the nonisolated group (33 vs. 58 days, p = .018). Two infants with syndromic RS received two interventions: One patient had a tracheotomy prior to MDO; another needed a tracheotomy directly after release of the TLA. Both were successfully decannulated afterwards.

Table 2.

Approach to infants with RS treated in the Wilhelmina Children’s Hospital 1996–2012

Total study group Isolated RS Nonisolated RS p value*
Number of patients 75 32 (43 %) 43 (57 %)
Conservative treatmenta 44 (59 %) 24 (75 %) 20 (47 %) 0.014
Surgical treatmentb 31 (41 %) 8 (25 %) 23 (53 %) 0.014
MDO 18 6 12
TLA 6 1 5
Tracheotomy 7 1 6
Mean age at surgical intervention in days (SD) 50 (55) 57 (42) 47 (60) 0.620
Mean duration of admission in days (SD)c 48 (43) 33 (35) 58 (45) 0.018
Conservatively treated group (SD) 30 (30) 24 (32) 35 (27) 0.285
Surgically treated group (SD) 73 (46) 55 (35) 80 (48) 0.163
Nasogastric tube 58 20 (63 %) 38 (88 %) 0.009

MDO mandibular distraction osteogenesis, TLA tongue lip adhesion, SD standard deviation

*p < 0.05 was considered statistically significant

aSide or prone positioning, supplemental oxygen, mayotube, or nasopharyngeal airway

bThe first surgical intervention was counted

cTotal duration of all hospital admissions related to airway or feeding problems in the first year of age

Fig. 1.

Fig. 1

Use of a nasopharyngeal airway as conservative treatment option in a 1-month-old infant with RS

Seventy-seven percent of all infants received temporary nasogastric (NG)-tube feeding during an average of 247 days. Average duration of NG-tube feeding was significantly longer in the surgically treated group than in the conservative treated group (resp. median: 72 days; mean rank: 30.5 vs. median: 21 days mean rank: 19.7, p = .008). Presence of NG-tube feeding showed a highly significant relation with mean duration of admission (p = .000); patients who had received NG-tube feeding were longer admitted in the hospital (44.2 days; SD, 39.1) as compared to patients who had not received NG-tube feeding (4.1 days; SD, 3.6).

Fourteen infants needed temporarily endotracheal intubation prior to surgical intervention, due to severe respiratory distress. Eleven were successfully extubated after surgery. Six infants (8 %), all syndromic RS, ultimately died due to cardiac or pulmonary pathology at a mean age of 416 days (44 days–3 years). All had been immediately intubated within several days after birth. One child was diagnosed with 4q deletion syndrome and received a TLA 23 days after birth and, subsequently, a tracheostomy 52 days after birth. He died due to a cardiac arrhythmia 10 months after the surgery. An infant with Yunis–Varon syndrome underwent TLA after 20 days but could not be extubated, and ultimately died after 41 days due to severe respiratory obstruction. Another infant with Treacher Collins who was primarily treated successfully with MDO 2 weeks after birth, died at almost 2 years of age due to aspiration pneumonia. A child with spondyloepiphyseal dysplasia died 44 days after a tracheotomy due to cardiac failure. Another child with psychomotor retardation, recurrent feeding difficulties, and an atrial and ventricle septum defect died possibly due to a cardiac problem at the age of 9 months. At the request of the parents, no autopsy was performed. Finally, a patient with severe psychomotor retardation, blindness, epilepsia, gastroesophageal reflux, and recurrent pneumonias died at 3 years of age due to sepsis en respiratory insufficiency after an aspiration pneumonia.

Literature review

The literature search yielded a total of 393 articles. Duplicates were excluded, and abstracts were further analyzed for relevance. Five literature studies [7, 9, 16, 27, 28], 25 retrospective case studies [8, 10, 14, 19, 20, 2948] and one prospective cohort study [49] fulfilled our selection criteria and were included for further analysis. There was final agreement between the two authors regarding the inclusion process. A summary of the approach described in these articles is listed in Table 3.

Table 3.

Approaches described in current literature until January 2014

Study Populationa Performed examinationb Indication for (surgical) intervention Type of interventionc (%)
Abel et al. (2012) [10]

N: 104

MG, Gl, CP

iRS, sRS

Overnight sleep study

Microlaryngobronchoscopy when Tr was considered

Moderate ( ≥3 clusters, ≥3 sPO2, 80–85 %) or severe ORD (≥3clusters, ≥3 sPO2, <80 %) not responding on positioning and NPA Tr 19 %
Augarten et al. (1990) [43]

N: 8

MG, Gl, CP

Monitoring of vital parameters, blood gases and weight gains

Lateral neck radiographs

Respiratory rates ≥60/min, requirement of ≥60 % O2, PaO2 ≤ 65 mmHg and PaCO2 ≥ 60 mmHg or acidemia, despite positioning

TLA

Tr if no improvement after TLA

38 %
Benjamin et al. (1991) [19]

N: 26

MG/RG, Gl

iRS, sRS

Pulse oximetry

Laryngoscopy before endotracheal intubation

Oxygen saturation <90 % for >10 % of the time not improving by position or NPA

Endotracheal intubation

Tr if this fails, to bypass obstruction

23 %
Bull et al. (1990) [30]

N: 21

RS (not specified)

iRS, sRS

Modified PSG during 2 h

When indicated: nasoendoscopy, airway fluoroscopy, upper GI radiographs and scintiscan and head CT

Suggestive/gastroesophageal reflux but normal radiographic studies: pH probe during PSG

↑ End tidal CO2 or uncorrectable desaturation (<90 % in >5 % of the sleep time or <80 % in 1 % of the sleep time) with 2 L nasal O2

Continued failure to thrive despite nutritional and oxygen supplementation

TLA or Tr 48 %
de Buys Roessingh et al. (2007) [29]

N: 48

MG/RG, Gl, ORD, CP

iRS, sRS

Pulse oximetry

Serial blood gas (every 2 days)

Nasoendoscopy, bronchoscopy, pH probe

PSG if monitoring shows bad results

Desaturation < 90 % with clinical evidence of respiratory distress or chronic CO2 retention (BE > 6.5) despite CPAP followed by NPA and palatal plate TLA, Tr 0 %
Caoutte Laberge et al. (1994) [31]

N: 125

MG/RG, Gl, ORD

iRS, sRS

Serial blood gas measurement

Oxygen saturation monitoring

Modified PSG (according to Freed et al. 1988)

PO2 < 60 mmHg or PCO2 > 50 mmHg Subperiosteal release of the floor of the mouth musculature or TLA; Tr if no relieve of UAO 18 %
Cheng et al. (2010) [32]

N: 20

MG, Gl, ORD

Continuous oxygen saturation measurement

Laryngoscopy and bronchoscopy before MDO

Preoperative PSG

Extensive periods of desaturations

<90 % not responding on CPAP

MDO + TLA 30 %
Cole et al. (2008) [33]

N: 39

MG, Gl, CP

Weight gain and saturation monitoring Moderate to severe respiratory distress when nursed side to side or with NPA No surgical intervention performed 0 %
Cruz et al. (1999) [34]

N: 47

MG, Gl, CP

iRS, sRS

PSG, nasoendoscopy

Laryngoscopy, and consideration of flexible and or rigid bronchoscopy before invasive treatment

Speech/swallow team evaluation using oropharyngeal motility studies

No resolve of the “airway difficulty” with positioning or short-term use of an NPA

TLA

Tr in (sub)glottic pathology or other

swallowing or neuromuscular difficulties

43 %
Dauria et al. (2008) [35]

N: 9

MG, ORD

iRS

Laryngoscopy and bronchoscopy

3D CT before distraction

Failure of positioning or NPA

Tr

MDO if no compounding pathology and /or gestational age >39 weeks

44 %
Evans et al. (2011) [7] Literature study

Modified PSG is important in early infancy for CO2 retention in addition to hypoxemia or desaturation, overnight full PSG may have a role when clinical picture is not clear

Laryngoscopy and bronchoscopy

No airway stability (abnormal oxygen saturations, carbon dioxide levels, presence of work of breathing and signs of airway obstruction) maintained by positioning or NPA

Temporarily endotracheal intubation

TLA/MDO: Single level tongue base obstruction

Tr: >1 level of obstruction or not a candidate for TLA/MDO

van den Elzen et al. (2001) [8]

N: 74

MG, CP, Gl

iRS, sRS

Continuous pulseoximetry

PSG on indication, not routinely performed

Hypoxia (continuous and persistent SpO2 levels <90 %) not responding on positioning or NPA

Endotracheal intubation

Tr (if no successful extubation within 4–6 weeks or after repeated intubations)

15 %
Freed et al. (1988) [36]

N: 6

MG, CP, Gl, ORD

iRS, sRS

Transcutaneous oxygen and transcutaneous carbon dioxide levels during a minimum of 8 h (range 8–18 h)

Modified PSG

Studied in lateral, prone and supine position for ≥45 min

Average oxygen levels <60 mmHg and CO2 levels >60 mmHg during ≥8 h

Any O2 level <80 %

Obstructive episodes on PSG

TLA 67 %
Gangopadhyay et al. (2012) [44] Not mentioned

Continuous pulse oximetry

PSG can be a useful tool

Inadequate results on sleep studies and poor weight gain despite positioning, supplemental O2 and NPA TLA or MDO (both options discussed with parents and team) Not mentioned
Gilhooly et al. (1992) [37]

N: 15

MG, Gl, ORD

iRS, sRS

4-channel PSG including ECG “Event of obstruction” of ≥15 s during sleep or quiet activity or shorter episodes associated with ↓ HR < 80 BPM or sPO2 < 85 % despite positioning TLA 40 %
Glynn et al. (2011) [20]

N: 69

MG, Gl, CP

iRS, sRS

Nasoendoscopy

Continuous oxygen saturation monitoring for 24–36 h

Hearing assessment with otoscopy, tympanometry, visual response and pure audiometry

Microlaryngobronchoscopy before Tr

SpO2 < 90 % >5 % of the time, despite positioning and NPA

Endotracheal intubation

Tr if attempts to extubate fail

14 %
Hoffman et al. (2003) [46]

N: 72

MG, Gl, ORD, CP

iRS, sRS

Clinical examination

PSG

Bronchoscopy

Average transcutaneous O2 < 60 mmHg/CO2 > 50 mmHg, SpO2 < 880 %, and/or obstructive episodes on sleep study despite positioning and supplemental oxygen

TLA

Tr for (sub)glottic pathology

35 %
Jarrahy et al. (2012) [27] Literature study

CT scan, manometry, electromyography, 24 h pH monitoring, and nuclear medicine imaging to evaluate presence of reflux

Nasoendoscopy pre- and postoperative, “sleep evaluation”

Failure of positioning/NPA orunsuitable airway for a trial of nonsurgical management

Subperiostal floor of mouth release

TLA, MDO, Tr

Kochel et al. (2010) [14]

N: 7

MG, Gl, ORD +/− CP

iRS, sRS

Nasoendoscopy

Continuous pulse oximetry

Blood gas analyses

Clinical signs of respiratory distress (i.e., agitation, dyspnea, tachypnea, intercostal recession, etc.) or oxygen desaturation or respiratory acidosis in blood gas analyses Orthopedic oral appliance with/without extension (posterior, extra oral or pharyngeal tube) 100 %
Van Lieshout et al. (2013) [38]

N: 59

MG/RG, ORD

iRS, sRS

PSG (in all infants with ORD despite prone positioning or with persistent feeding difficulties)

Nasoendoscopy on indication

Failure of prone positioning and respiratory support (NPA, CPAP, and/or oxygen supplementation) Tr and/or MDO 7 %
Mackay et al. (2011) [16] Literature study

Evaluation of desaturation occurring spontaneously, during feeding and sleep

Nasoendoscopy, bronchoscopy

PSG, pH monitoring, CT scan and cephalometrics

Persistent obstruction despite positioning or NPA

TLA

MDO (if TLA fails)

Tr (if MDO fails)

Marques et al. (2000) [49]

N: 62

RG, Gl, ORD

iRS, sRS

Nasoendoscopy

Continuous pulse oxymetry

SpO2 < 90 %, increasing respiratory effort and/or no removal of NG tube possible despite NPA within 15 days

TLA (type 1 obstruction)

Tr (type 3 or 4 obstruction, or no improvement after TLA/NPA)

35 %
Poets and Bacher (2011) [9] Literature study

Clinical observation

PSG

Significant UAO during sleep, defined as a mixed-obstructive apnea index (MAOI) > 3 in a sleep study Pre-epiglottic baton plate
Schaefer et al. (2003) [41], Schaefer et al. (2004) [42]

N: 21

max–min. discrepancy of >3 mm, Gl, +/− CP

Pulse oximetry for ≥12 h, PSG (continuous monitoring oxygen saturation, end-tidal CO2 and EEG during sleep), nasoendoscopy and bronchoscopy before invasive intervention Any single saturation below the 80 % or PO2 < 90 % for >5 % of the monitored time despite positioning

TLA

MDO (if TLA fails)

Tr if no response to TLA/MDO or (infra)glottic problem present

57 %
Scott et al. (2012) [28] Literature study

Nasoendoscopy

PSG if no life threatening airway compromise is present

Serial capillary blood gases (to document a trend of elevated or increasing carbon dioxide levels)

Continuous-pulse oximetry and cardiac monitoring

Signs of upper airway obstruction despite prone- or side positioning or NPA TLA, Tr, MDO
Thouvenin et al. (2013) [48]

N: 141

RG, Gl, CP iRS, sRS

Continuous monitoring of cardiac and respiratory rhythms, regularly check of transcutaneous PO2 and PCO2 levels. PSG on indication

Karyotype assay, echocardiography, skeletal radiography, ophthalmologic examination

Oxygen saturation < 90 % for >5 % of the time or saturations < 80 % not responding on positional changes or NPA Tr Not mentioned
Tomaski et al. (1995) [47]

N: 90

MG, Gl, CP

iRS, sRS

Flexible fiberoptic nasopharyngolaryngoscopy, cardiac and pulmonary evaluation, chest radiogram, electrocardiogram, ophthalmologic and genetics consultation

PSG, continuous pulse oximetry, and apnea monitoring

Pre-op: lateral X-ray, rigid direct laryngoscopy and bronchoscopy

Positioning and NPA are not successful in relieving airway obstruction Tr 12 %
Wagener et al. (2003) [39]

N: 22

MG, ORD, Gl, CP

iRS, sRS

Continuous oxygen saturation monitoring Severe UAO (cyanotic attack, transcutaneous oxygenation > 90 %, PCO2 < 50 mmHg) not responding on positioning or NPA No surgical intervention necessary 0 %

Vyas et al. (2008) [40]

Kohan et al. (2010) [45]

N: 149

MG, ORD

iRS, sRS

PSG

Radionuclide milk scan (severity of gastroesophogeal reflux and gastric emptying) with 24-h pH probe (in indeterminate results) and laryngobronchoscopy

Intubation at birth necessary, failed extubation or failed conservative treatment (prone positioning or NPA)

MDO

Tr if: 1. Central apnea 2. Severe gastroesophageal reflux 3. Other airway lesions

78 %

MG/RG micrognathia/retrognathia, Gl glossoptosis, ORD obstructive respiratory distress, CP cleft palate, iRS isolated Robin sequence, sRS syndromal Robin sequence, PSG polysomnography, Tr tracheotomy, TLA tongue lip adhesion, MDO mandibular distraction osteogenesis

Wilhelmina Children’s Hospital approach

Our treatment algorithm is presented in Fig. 2. Infants diagnosed with RS are initially treated in prone or side position when their condition allows it. Prior to any decision making, the patient is observed for at least 24 h. Monitoring of vital parameters, measurements of oxygen saturation by continuous pulse oximetry, capillary blood gas analysis, and more recently transcutaneous carbon dioxide measurements (Tosca®) are performed [5052]. Observation of clinical signs of respiratory distress during sleep and awake, as well as feeding ability, are documented by experienced nursing and medical staff. We consider oxygen saturations of <90 % for >5 % of the monitored time and/or any single desaturation <80 % as a sign of UAO [39, 41, 42]. Blood gas analysis revealing respiratory acidosis (pCO2 > 50 mmHg, HCO3 > 30 mmHg) or transcutaneous CO2 > 50 mmHg during >25 % of the total sleep time is indicative of hypoventilation [53]. Results are discussed in a multidisciplinary setting consisting of at least a pediatrician, plastic surgeon, otolaryngologist, and a pediatric intensive care specialist after 24–48 h of monitoring. A clinical geneticist is always consulted. Based on the observations and measurements, patients are divided into mild UAO or moderate/severe UAO. These characteristics are described in Fig. 2.

Fig. 2.

Fig. 2

Algorithm of the institutional approach to infants with Robin sequence

Patients with RS with mild UAO remain closely monitored in prone or side position (Fig. 2). Depending on the clinical condition, measurements are repeated and reassessed. Poor weight gain is defined as <150 g/week [41]. In these cases, further analysis by a pediatrician is indicated, and NG-tube feeding may be necessary [37, 54]. If the before-mentioned measurements remain normal, patients will be discharged after the parents are sufficiently instructed. Pulse oximetry is continued at home for an average of 3 months, and at least once a month, the pediatric outpatient department is visited.

In moderate to severe UAO, the location of the airway obstruction should be investigated by direct flexible laryngoscopy to localize the site of obstruction and to identify possible other airway comorbidities that would influence the decision-making process [55] (Fig. 2). True glossoptosis or other supraglottic obstruction can be diagnosed by this measure (Fig. 3). If the clinical symptoms cannot or only partially be explained by the visible airway obstruction, an overnight polysomnography (PSG) is warranted. Hereby, central apneas, mixed apneas, or episodes of obstructive apnea can be diagnosed, as the glossoptosis tends to be a dynamic problem and could not be identified with laryngoscopy. If substantial central or mixed apnea is detected, a specialist in pulmonary or sleep medicine is consulted. Once the diagnosis of a supraglottic/tongue base obstruction is made, an NPA or mayotube is inserted to maintain a patent airway, and the infant is closely monitored. It is important to mention that other options for conservative treatment, such as orthopedic appliances (like palatal plates or the pre-epiglottic baton plate), have been described to date [1214]. However, these are not implemented in our algorithm as we are currently not familiar with the use of it in our institution. In the most severe cases of UAO (i.e., micrognathia with severe clinical signs of respiratory obstruction, any single desaturation <80 % or severe respiratory acidosis despite positioning) immediate MDO or TLA could be anticipated. However, in our institution, we advocate a trial period of NPA prior to any surgical measure. Depending on the clinical condition of the infant, the case is then reassessed in our team after several days of continuous and cautious monitoring. If earlier-mentioned measurements and observations are normal and the infant shows sufficient weight gain, NPA treatment will be continued. If the infant shows deterioration despite NPA, the surgical options will be discussed with the parents. Until 2006, either TLA or tracheotomy was performed. However, after 2006, MDO has become our surgical procedure of preference when a supraglottic obstruction and a true micrognathia together with a normal functioning temporomandibular joint are present [56]. Before surgery is pursued, other pathology should be ruled out by flexible laryngotracheobronchoscopy. Moreover, radiological assessment of the mandible with a lateral X-ray or CT scan is obtained (Fig. 4). Our performed technique with a resorbable internal distraction apparatus has been described previously [23, 24]. Occasionally, when patients do not have a very small mandible but evident glossoptosis is present, TLA is performed. Still, as it is difficult to accurately assess the mandibular size in infants, often, both procedures and their (dis)advantages are discussed in our team and with the parents. After surgery, vital parameters and blood gasses with pulse oximetry should be regular reassessed.

Fig. 3.

Fig. 3

Example of glossoptosis evaluated by direct flexible laryngoscopy

Fig. 4.

Fig. 4

Example of micrognathia seen on lateral X-ray

In our cohort, 29 infants (39 %) suffered mild RS according to our classification. Of these, four (14 %) had to be subsequently treated according the moderate/severe limb of the algorithm, of whom one patient ultimately received a tracheostomy. Forty-six (61 %) of the admitted infants were initially classified as moderate/severe RS and treated accordingly. Of these, 30 infants (47 %) were treated surgically.

Discussion

The current study was performed due to the paucity of treatment algorithms for infants with RS in the literature. A plethora of different treatment modalities is suggested, but decisions and rational on which the interventions are based are variable and often ambiguous. A more standardized approach to this challenging clinical entity should be used. An efficient strategy with a multidisciplinary approach might decrease mortality and morbidity, as possible respiratory and feeding problems may be more quickly recognized and treated more efficient [31]. By a thorough retrospective analysis of the treatment regime in our institution and a review of the current literature, we have developed recommendations in the form of an algorithm, which could be applied as a guidance for other centers involved in the care for infants with RS.

The understanding of RS is among others hampered by the numerous different definitions that are used to describe this condition [26, 5759]. Most authors of the analyzed studies use the criteria described by Pierre Robin in 1934, thus presence of micrognathia, glossoptosis, respiratory distress, and a cleft palate (Table 3) [2]. According to others, in our institution, we define the disorder as presence of micrognathia combined with signs of UAO [38]. Sometimes, we encounter difficulty in determining glossoptosis, possibly due to the fact that intra-oral inspection does not immediately have to reveal its presence and no easy applicable scale of measurement exists. Glossoptosis can be a dynamic problem in which the degree of “ptosis” of the tongue, and subsequent upper airway obstruction, varies, depending on the position and state of the infant (for example asleep, during feeding or tired). Moreover, UAO in patients with micrognathia does not necessarily indicate glossoptosis, since other or additional causes for airway obstruction might be present (e.g., neurologic abnormalities, pharyngeal hypotonia, or choanal atresia) in RS [3, 55]. Therefore, we advice to perform a flexible laryngoscopy in cases with moderate/severe UAO to quickly obtain more information about this matter (Fig. 3). Endoscopic findings in RS have been clearly described and graded [55]. Finally, the presence of a cleft palate is not obligatory for the diagnosis, although it was encountered in 97 % of our patients [9, 44].

A common understanding in the literature is to start every treatment of an RS patient with conservative measures. In our series, more than half of the infants (59 %, n = 44) could be treated conservatively, which is comparable to others [30, 32, 34, 35, 37, 49]. Conservative treatment usually starts with prone or side positioning, which will reduce airway obstruction at tongue base level by allowing the mandible and tongue to fall forward. Some do advocate side positioning, since prone positioning might obscure signs of respiratory distress and makes it difficult for the parents to interact with their baby [33]. Supplemental oxygen can be provided when necessary by a nasal cannula. When positioning fails, use of an NPA, mayotube, or CPAP are frequently described secondary measures (Table 3). NPA has obtained a lot of interest and revealed good results (Fig. 1) [10, 29, 33, 39]. According to our approach, the majority of the authors starts using an NPA when positioning fails [8, 10, 16, 19, 20, 2729, 3335, 3840, 44, 45, 4749]. As we have obtained feasible results, we currently use NPA in every infant with significant UAO before a surgical measure is initiated, and no longer apply a mayotube or CPAP. Yet, the exact place of CPAP still needs to be defined in the treatment of RS. Certain drawbacks of NPA are known. Duration of treatment, obstruction, or luxation of the tube, the burden of care for the parents when the child is discharged with NPA, and persistent feeding problems during the treatment have been described [10, 60]. Finally, also other conservative options, such as the custom-made palatal plate or pre-epiglottic baton plate (PEBP), have been described to date [12, 14, 15]. The promising results of a velar extension in the PEBP have been demonstrated in a randomized clinical trial regarding isolated RS infants [15]. It has also revealed positive effects on feeding issues [61]. The PEBP might completely obviate the necessity of a surgical intervention, by noninvasively moving the base of the tongue forward and subsequently widening the oropharynx. It is speculated that this protrusion of the tongue might also stimulate mandibular growth, although this has not yet been proven [13]. Still, when using these orthopedic appliances, it is necessary to have an experience team, including skilled nurses who can guide and train parents in handling the PEBP [9]. As demonstrated in the literature, the training during residency is of paramount importance regarding what technique will be utilized in the institution [25]. However, the country and the supporting medical system will also influence the decision making in what the most useful conservative treatment option will be.

The percentage of infants that need invasive treatment differs from 0 to 78 % [14, 29, 33, 39, 40, 45] in medical literature (Table 3). These varying percentages are illustrative of the difficulty to accurately define at which exact point the infant fails to respond to conservative treatment and a surgical intervention is anticipated. Many authors tend to use cut-off values derived from specific tests such as PSG or blood measurements to determine candidacy for surgery [10, 19, 20, 2932, 36, 37, 39, 41, 42, 44, 46, 47] (Table 3). While we also take account of oxygen saturations and CO2 levels, we strongly recommend that the multidisciplinary team considers all available results including clinical observation and feeding status, when deciding about escalating care (Fig. 2). Standard usage of PSG in the management of RS remains a point of discussion [7, 28, 29, 37, 62]. In accordance to others and as demonstrated in the flowchart, in our institution, PSG is only performed on indication, to exclude central apneas or to quantify more subtle airway obstruction if the clinical symptoms cannot or only partially be explained by the visible airway obstruction (Fig. 2) [7, 19, 20, 29, 37, 39] In the majority of the studies that used PSG routinely, a so-called “modified PSG” is performed using only certain components of PSG [31, 32, 36, 37, 41, 42, 46]. It is mandatory that important matters such as the exact indication, frequency, and the extensiveness of the conducted tests on PSG are clarified in further studies, and strict recommendations for its use can be made.

Forty-one percent of the infants of our cohort needed a surgical intervention, comparable to findings described by others [29, 30, 34, 35, 37, 43, 46]. In the analyzed literature, surgical interventions consist mainly of TLA [20, 2831, 34, 36, 37, 4143, 46, 49] or MDO when TLA failed [16, 41, 42] (Table 3). Some recommended MDO as primary measure [35, 40, 45] or a combination of MDO and TLA [32]. Generally, tracheotomy was considered as final option when there was no improvement after TLA and/or MDO [7, 16, 27, 28, 31, 34, 35, 4143, 46, 49]. Other indications were the presence of a central neurological impairment or coinciding upper airway [i.e. (sub)glottic obstruction or tracheo- or laryngomalacia], cardiac, pulmonary, or gastroesophageal pathology, contributing to the respiratory distress [7, 27, 28, 30, 34, 35, 4042, 44, 46]. Still, some authors choose tracheotomy as the primary surgical strategy after conservative treatment has failed [10, 19, 20, 47, 48, 63]. In our series, MDO was the primary choice in more than half of the surgically treated cases (Table 2). Until 2006, TLA was our surgical procedure of preference with subsequent tracheotomy if TLA failed or could not be performed due to (sub)glottic pathology. At this moment, we only perform TLA in the rare cases where patients have an obvious glossoptosis without clear micrognathia. Objectively assessing the size of micrognathia is not easy, and currently, the (dis)advantages of both MDO and TLA are discussed in a multidisciplinary team meeting and with the parents. It is important to emphasize the risk of glossoptosis recurring after TLA release [64]. MDO also proves to be more effective than TLA in resumption of normal oral feeding [65]. In our series, all children could bottle feed within 4 weeks after distraction and NG-tube feeding could be stopped [24]. Additionally, since we use a resorbable distracting system, there is no need for a second intervention, while patients with TLA need secondary surgery to release the adhesion [24]. Finally, there is less scar formation after MDO [66]. However, long-term follow-up studies after MDO in RS patients are still scarce. Furthermore, possible damage to the permanent molars in the osteotomy region and mandibular outgrow after MDO remains a point of investigation and discussion. In order to clarify these matters, analyses are currently undertaken at our institution.

Six infants (8 %) of our cohort, all nonisolated RS patients, died after a mean of 416 days (44 days–3 years). Reported mortality rates in the literature vary from 0 up to 26 % [8]. It is important to realize that RS is a heterogenic disorder with numerous causes and also possible co-morbidities, which can aggravate the already present symptoms [44]. An additional syndrome or malformation makes the treatment regime especially challenging and a multidisciplinary approach indispensable. In 75 % of the infants with isolated RS, conservative measures revealed to be sufficient to maintain an adequate airway. In contrast, of the nonisolated infants, only 47 % could be treated conservatively (Table 2). This important, significant finding (p = 0.014) demonstrates the relevance of adequate and early genetic analysis. Less favorable airway outcomes are more common in nonisolated RS, potentially attributed to airway and swallowing problems independent of glossoptosis [28, 31, 47, 67]. In addition, mandibular size and morphology vary significantly in syndromic RS [68]. Although we are aware that an associated syndrome could have important consequences for the long-term mandibular outgrowth, this does not influence our initial treatment approach, as the respiratory distress still needs to be treated and will be alleviated by advancing the mandible. However, MDO or other surgical interventions should only be considered after other or additional etiologies of respiratory compromise (such as tracheo-or laryngeomalacia) are ruled out. Furthermore, it needs to be addressed that conservative measures can obtain good results and should always be performed in first instance, also in syndromic RS infants [14].

It is still not fully elucidated what risk factors exist and which infants have an absolute contraindication to receive surgery. Murage and co-workers reviewed the results of 50 infants who were treated with MDO and concluded that the absence of a CP, presence of gastroesophageal reflux, and need for Nissen fundoplication might be associated with failure of MDO [69]. Prematurity, low birth weight, late operation, preoperative intubation, diagnosis of a syndrome, and cardiac and pulmonary abnormalities did not preclude success in appropriately selected patients [69]. On the contrary, others demonstrated that, besides gastroesophageal reflux, also preoperative intubation, late operation (older than 2 weeks), low birth weight, and diagnosis of a syndrome were significant predictive markers of failure of TLA and necessity of a tracheotomy [67, 70]. The cited studies are retrospective and may contain substantial bias. Prospective studies, systematically collecting data, are needed to understand risk factors for failure and success of interventions and to develop evidenced based clinical guidelines to facilitate treatment planning.

Besides the airway problems, feeding difficulties are also a common finding in infants with RS and should be adequately supported [7, 71]. Seventy-seven percent (n = 58) of the infants in our series needed NG-tube feeding during an average of 247 days. This comprised of significantly more infants of the nonisolated group (88 %), compared to 63 % of the isolated RS patients (p = .009). Duration of NG-tube feeding was also significantly shorter in the conservative treated group (p = .008). However, in all cases after MDO, NG-tube feeding could be successfully stopped within 4 weeks postoperatively, independent of the syndromic or nonsyndromic status. Feeding difficulties in RS can have multiple causes [61], on the one hand attributed to the micrognathia, glossoptosis, or the possible concomitant cleft palate, and also to possible additional upper digestive tract motor dysfunction, leading to esophageal motility disorders or reflux disease. Associated cardiac or other complex abnormalities can also lead to compromised growth [7]. In persistent feeding problems, we advice consulting a pediatrician or pediatric neurologist to rule out other pathology.

One of the strengths of the current study is that it gives a clear insight of the treatment in a relatively large cohort of infants with RS, and a structured and pragmatic algorithmic approach including the rationale of the decisions taken. This could be used as guidance in other institutions. Moreover, it provides a clear overview of approaches described in the literature. Limitations include a possible selection bias as this is a tertiary center. In addition, the retrospective nature of the study and the relatively short follow-up period should be emphasized. Finally, we are fully aware that our approach could differ from the supporting medical system and regional habits of other institutions. Other treatment options, such as orthopedic appliances, have been described in the current literature yielding very good results [9, 13, 14]. Yet, in our institution, we do not have experience in using them. However, this does not preclude their beneficial use in infants with RS in other practices.

It should be addressed that many different treatment options could probably be performed on a patient. Each intervention has known (dis)advantages and the outcome depends on multiple factors. Burden of care, treatment duration, long-term complications, and financial implications should be considered [65, 66, 72, 73]. Furthermore, surgical skills and preferences will influence the approach of the treatment center [25]. It is demonstrated that mortality and morbidity are significantly lower in infants treated by the use of a decisional model [40, 45]. However, the choice of a specific treatment for an infant with RS is a continuous and dynamic process, with multiple factors to be regarded and with many caretakers involved. The algorithm, as presented in the current study, should be used as a guideline and not as a rigid decision tree since every patient is unique. Still, using an algorithm, we hope to prevent possible unnecessary proceedings and a potential delay in treatment by helping involved caretakers in decision making. Prospective studies will give us more insight in the outcome of the different strategies, which unfortunately do not exist to date. Using an algorithm, it might be easier to compare the outcome of the different modalities in the nearby future.

Conclusion

RS is a heterogeneous disorder with numerous different treatment strategies described to date. A pragmatic approach is presented in this manuscript. The management of RS involves a multidisciplinary team approach to achieve a safe airway and adequate growth. We hope that this manuscript will serve as a guidance for caretakers involved in the care for infants with RS and as an impetus for conducting future (preferably prospective) studies.

Acknowledgments

The authors thank Mr. Victor H.C. van den Berg for his technical support in the design of the algorithm and Mr. Gregory Hayles for his assistance in English grammar and language.

Conflict of interest

No conflicts of interest to disclose by any author.

Funding source

No funding was secured for this study.

Financial disclosure

No financial relationships relevant to this article to disclose.

References

  • 1.Robin P. La chute de la base de la langue considérée comme une nouvelle cause de gans la respiration naso-pharyngienne. Bull Acad Natl Med. 1923;89:37–41. [Google Scholar]
  • 2.Robin P. Glossoptosis due to atresia and hypotrophy of the mandible. Am J Dis Child. 1934;48:541–547. [Google Scholar]
  • 3.Shprintzen RJ. The implications of the diagnosis of Robin sequence. Cleft Palate Craniofac J. 1992;29:205–209. doi: 10.1597/1545-1569(1992)029&#x0003c;0205:TIOTDO&#x0003e;2.3.CO;2. [DOI] [PubMed] [Google Scholar]
  • 4.Vatlach S, Maas C, Poets CF. Birth prevalence and initial treatment of Robin sequence in Germany: a prospective epidemiologic study. Orphanet J Rare Dis. 2014;9:9-1172-9-9. doi: 10.1186/1750-1172-9-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bush PG, Williams AJ. Incidence of the Robin Anomalad (Pierre Robin syndrome) Br J Plast Surg. 1983;36:434–437. doi: 10.1016/0007-1226(83)90123-6. [DOI] [PubMed] [Google Scholar]
  • 6.Printzlau A, Andersen M. Pierre Robin sequence in Denmark: a retrospective population-based epidemiological study. Cleft palate. Craniofac J. 2004;41:47–52. doi: 10.1597/02-055. [DOI] [PubMed] [Google Scholar]
  • 7.Evans KN, Sie KC, Hopper RA, et al. Robin sequence: from diagnosis to development of an effective management plan. Pediatrics. 2011;127:936–948. doi: 10.1542/peds.2010-2615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.van den Elzen AP, Semmekrot BA, Bongers EM, et al. Diagnosis and treatment of the Pierre Robin sequence: results of a retrospective clinical study and review of the literature. Eur J Pediatr. 2001;160:47–53. doi: 10.1007/s004310000646. [DOI] [PubMed] [Google Scholar]
  • 9.Poets CF, Bacher M. Treatment of upper airway obstruction and feeding problems in Robin-like phenotype. J Pediatr. 2011;159:887–892. doi: 10.1016/j.jpeds.2011.07.033. [DOI] [PubMed] [Google Scholar]
  • 10.Abel F, Bajaj Y, Wyatt M, et al. The successful use of the nasopharyngeal airway in Pierre Robin sequence: an 11-year experience. Arch Dis Child. 2012;97:331–334. doi: 10.1136/archdischild-2011-301134. [DOI] [PubMed] [Google Scholar]
  • 11.Mondini CC, Marques IL, Fontes CM, et al. Nasopharyngeal intubation in Robin sequence: technique and management. Cleft Palate Craniofac J. 2009;46:258–261. doi: 10.1597/08-042.1. [DOI] [PubMed] [Google Scholar]
  • 12.Butow KW, Hoogendijk CF, Zwahlen RA. Pierre Robin sequence: appearances and 25 years of experience with an innovative treatment protocol. J Pediatr Surg. 2009;44:2112–2118. doi: 10.1016/j.jpedsurg.2009.04.018. [DOI] [PubMed] [Google Scholar]
  • 13.Bacher M, Sautermeister J, Urschitz MS, et al. An oral appliance with velar extension for treatment of obstructive sleep apnea in infants with pierre robin sequence. Cleft Palate Craniofac J. 2011;48:331–336. doi: 10.1597/09-091. [DOI] [PubMed] [Google Scholar]
  • 14.Kochel J, Meyer-Marcotty P, Wirbelauer J, et al. Treatment modalities of infants with upper airway obstruction—review of the literature and presentation of novel orthopedic appliances. Cleft Palate Craniofac J. 2011;48:44–55. doi: 10.1597/08-273. [DOI] [PubMed] [Google Scholar]
  • 15.Buchenau W, Urschitz MS, Sautermeister J, et al. A randomized clinical trial of a new orthodontic appliance to improve upper airway obstruction in infants with Pierre Robin sequence. J Pediatr. 2007;151:145–149. doi: 10.1016/j.jpeds.2007.02.063. [DOI] [PubMed] [Google Scholar]
  • 16.Mackay DR. Controversies in the diagnosis and management of the Robin sequence. J Craniofac Surg. 2011;22:415–420. doi: 10.1097/SCS.0b013e3182074799. [DOI] [PubMed] [Google Scholar]
  • 17.Bijnen CL, Don Griot PJ, Mulder WJ, et al. Tongue–lip adhesion in the treatment of Pierre Robin sequence. J Craniofac Surg. 2009;20:315–320. doi: 10.1097/SCS.0b013e31819ba5ce. [DOI] [PubMed] [Google Scholar]
  • 18.Mokal NJ, Desai MF and Sawant P (2014) Reinventing the technique of tongue–lip adhesion in Pierre Robin sequence. J Plast Reconstr Aesthet Surg 67(3):415–417 [DOI] [PubMed]
  • 19.Benjamin B, Walker P. Management of airway obstruction in the Pierre Robin sequence. Int J Pediatr Otorhinolaryngol. 1991;22:29–37. doi: 10.1016/0165-5876(91)90094-R. [DOI] [PubMed] [Google Scholar]
  • 20.Glynn F, Fitzgerald D, Earley MJ, et al. Pierre Robin sequence: an institutional experience in the multidisciplinary management of airway, feeding and serous otitis media challenges. Int J Pediatr Otorhinolaryngol. 2011;75:1152–1155. doi: 10.1016/j.ijporl.2011.06.009. [DOI] [PubMed] [Google Scholar]
  • 21.Breugem CC, Olesen PR, Fitzpatrick DG, et al. Subperiosteal release of the floor of the mouth in airway management in Pierre Robin sequence. J Craniofac Surg. 2008;19:609–615. doi: 10.1097/SCS.0b013e31816aab0b. [DOI] [PubMed] [Google Scholar]
  • 22.Caouette-Laberge L and Borsuk DE. (2012) Subperiosteal release of the floor of the mouth to correct airway obstruction in Robin sequence: review of 31 cases. Cleft Palate Craniofac J 49(1):14–20 [DOI] [PubMed]
  • 23.Burstein FD, Williams JK. Mandibular distraction osteogenesis in Pierre Robin sequence: application of a new internal single-stage resorbable device. Plast Reconstr Surg. 2005;115:61–67. [PubMed] [Google Scholar]
  • 24.Breugem C, Paes E, Kon M, et al. Bioresorbable distraction device for the treatment of airway problems for infants with Robin sequence. Clin Oral Investig. 2012;16:1325–1331. doi: 10.1007/s00784-011-0624-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Collins B, Powitzky R, Robledo C et al (2014) Airway management in Pierre Robin sequence: patterns of practice. Cleft Palate Craniofac J 51(3):283–289 [DOI] [PubMed]
  • 26.Basart H, Kruisinga FH, Breugem CC et al (2015) Will the right Robin patient rise, please? Definitions and criteria during management of Robin sequence patients in The Netherlands and Belgium. J Craniomaxillofac Surg 43(1):92–96 [DOI] [PubMed]
  • 27.Jarrahy R. Controversies in the management of neonatal micrognathia: to distract or not to distract, that is the question. J Craniofac Surg. 2012;23:243–249. doi: 10.1097/SCS.0b013e318241b90a. [DOI] [PubMed] [Google Scholar]
  • 28.Scott AR, Tibesar RJ, Sidman JD. Pierre Robin sequence: evaluation, management, indications for surgery, and pitfalls. OtolaryngolClinNorth Am. 2012;45:695–710. doi: 10.1016/j.otc.2012.03.007. [DOI] [PubMed] [Google Scholar]
  • 29.de Buys Roessingh AS, Herzog G, Hohlfeld J. Respiratory distress in Pierre Robin: successful use of pharyngeal tube. J Pediatr Surg. 2007;42:1495–1499. doi: 10.1016/j.jpedsurg.2007.04.024. [DOI] [PubMed] [Google Scholar]
  • 30.Bull MJ, Givan DC, Sadove AM, et al. Improved outcome in Pierre Robin sequence: effect of multidisciplinary evaluation and management. Pediatrics. 1990;86:294–301. [PubMed] [Google Scholar]
  • 31.Caouette-Laberge L, Bayet B, Larocque Y. The Pierre Robin sequence: review of 125 cases and evolution of treatment modalities. Plast Reconstr Surg. 1994;93:934–942. doi: 10.1097/00006534-199404001-00006. [DOI] [PubMed] [Google Scholar]
  • 32.Cheng AT, Corke M, Loughran-Fowlds A, et al. Distraction osteogenesis and glossopexy for Robin sequence with airway obstruction. ANZ J Surg. 2011;81:320–325. doi: 10.1111/j.1445-2197.2010.05588.x. [DOI] [PubMed] [Google Scholar]
  • 33.Cole A, Lynch P, Slator R. A new grading of Pierre Robin sequence. Cleft Palate Craniofac J. 2008;45:603–606. doi: 10.1597/07-129.1. [DOI] [PubMed] [Google Scholar]
  • 34.Cruz MJ, Kerschner JE, Beste DJ, et al. Pierre Robin sequences: secondary respiratory difficulties and intrinsic feeding abnormalities. Laryngoscope. 1999;109:1632–1636. doi: 10.1097/00005537-199910000-00016. [DOI] [PubMed] [Google Scholar]
  • 35.Dauria D, Marsh JL. Mandibular distraction osteogenesis for Pierre Robin sequence: what percentage of neonates need it? J Craniofac Surg. 2008;19:1237–1243. doi: 10.1097/SCS.0b013e3181843293. [DOI] [PubMed] [Google Scholar]
  • 36.Freed G, Pearlman MA, Brown AS, et al. Polysomnographic indications for surgical intervention in Pierre Robin sequence: acute airway management and follow-up studies after repair and take-down of tongue–lip adhesion. Cleft Palate J. 1988;25:151–155. [PubMed] [Google Scholar]
  • 37.Gilhooly JT, Smith JD, Howell LL, et al. Bedside polysomnography as an adjunct in the management of infants with Robin sequence. Plast Reconstr Surg. 1993;92:23–27. doi: 10.1097/00006534-199307000-00003. [DOI] [PubMed] [Google Scholar]
  • 38.van Lieshout MJ, Joosten KF, Hoeve HL et al (2014) Unravelling Robin sequence: considerations of diagnosis and treatment. Laryngoscope 124(5):E203–9 [DOI] [PubMed]
  • 39.Wagener S, Rayatt SS, Tatman AJ, et al. Management of infants with Pierre Robin sequence. Cleft Palate Craniofac J. 2003;40:180–185. doi: 10.1597/1545-1569(2003)040&#x0003c;0180:MOIWPR&#x0003e;2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 40.Vyas RM, Dipple KM, Head C, et al. Management of neonatal upper airway obstruction: decreased morbidity by utilizing a decision tree model with mandibular distraction osteogenesis. J Neonatal-Perinatal Med. 2008;1:21–29. [Google Scholar]
  • 41.Schaefer RB, Gosain AK. Airway management in patients with isolated Pierre Robin sequence during the first year of life. J Craniofac Surg. 2003;14:462–467. doi: 10.1097/00001665-200307000-00011. [DOI] [PubMed] [Google Scholar]
  • 42.Schaefer RB, Stadler JA, 3rd, Gosain AK. To distract or not to distract: an algorithm for airway management in isolated Pierre Robin sequence. Plast Reconstr Surg. 2004;113:1113–1125. doi: 10.1097/01.PRS.0000110323.50084.21. [DOI] [PubMed] [Google Scholar]
  • 43.Augarten A, Sagy M, Yahav J, et al. Management of upper airway obstruction in the Pierre Robin syndrome. Br J Oral Maxillofac Surg. 1990;28:105–108. doi: 10.1016/0266-4356(90)90133-6. [DOI] [PubMed] [Google Scholar]
  • 44.Gangopadhyay N, Mendonca DA, Woo AS. Pierre Robin sequence. Semin Plast Surg. 2012;26:76–82. doi: 10.1055/s-0032-1320065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kohan E, Hazany S, Roostaeian J, et al. Economic advantages to a distraction decision tree model for management of neonatal upper airway obstruction. Plast Reconstr Surg. 2010;126:1652–1664. doi: 10.1097/PRS.0b013e3181ef8e82. [DOI] [PubMed] [Google Scholar]
  • 46.Hoffman W. Outcome of tongue–lip plication in patients with severe Pierre Robin sequence. J Craniofac Surg. 2003;14:602–608. doi: 10.1097/00001665-200309000-00002. [DOI] [PubMed] [Google Scholar]
  • 47.Tomaski SM, Zalzal GH, Saal HM. Airway obstruction in the Pierre Robin sequence. Laryngoscope. 1995;105:111–114. doi: 10.1288/00005537-199502000-00001. [DOI] [PubMed] [Google Scholar]
  • 48.Thouvenin B, Djadi-Prat J, Chalouhi C et al (2013) Developmental outcome in Pierre Robin sequence: a longitudinal and prospective study of a consecutive series of severe phenotypes. Am J Med Genet A 161A:312–319 [DOI] [PubMed]
  • 49.Marques IL, de Sousa TV, Carneiro AF, et al. Clinical experience with infants with Robin sequence: a prospective study. Cleft Palate Craniofac J. 2001;38:171–178. doi: 10.1597/1545-1569(2001)038&#x0003c;0171:CEWIWR&#x0003e;2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 50.Kirk VG, Batuyong ED, Bohn SG. Transcutaneous carbon dioxide monitoring and capnography during pediatric polysomnography. Sleep. 2006;29:1601–1608. doi: 10.1093/sleep/29.12.1601. [DOI] [PubMed] [Google Scholar]
  • 51.Tobias JD. Transcutaneous carbon dioxide monitoring in infants and children. Paediatr Anaesth. 2009;19:434–444. doi: 10.1111/j.1460-9592.2009.02930.x. [DOI] [PubMed] [Google Scholar]
  • 52.Tobias JD, Meyer DJ. Noninvasive monitoring of carbon dioxide during respiratory failure in toddlers and infants: end-tidal versus transcutaneous carbon dioxide. Anesth Analg. 1997;85:55–58. doi: 10.1097/00000539-199707000-00010. [DOI] [PubMed] [Google Scholar]
  • 53.Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8:597–619. doi: 10.5664/jcsm.2172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Evans AK, Rahbar R, Rogers GF, et al. Robin sequence: a retrospective review of 115 patients. Int J Pediatr Otorhinolaryngol. 2006;70:973–980. doi: 10.1016/j.ijporl.2005.10.016. [DOI] [PubMed] [Google Scholar]
  • 55.Sher AE. Mechanisms of airway obstruction in Robin sequence: implications for treatment. Cleft Palate Craniofac J. 1992;29:224–231. doi: 10.1597/1545-1569(1992)029&#x0003c;0224:MOAOIR&#x0003e;2.3.CO;2. [DOI] [PubMed] [Google Scholar]
  • 56.Kaban LB, Moses MH, Mulliken JB. Surgical correction of hemifacial microsomia in the growing child. Plast Reconstr Surg. 1988;82:9–19. doi: 10.1097/00006534-198882010-00003. [DOI] [PubMed] [Google Scholar]
  • 57.Cohen MM., Jr Robin sequences and complexes: causal heterogeneity and pathogenetic/phenotypic variability. Am J Med Genet. 1999;84:311–315. doi: 10.1002/(SICI)1096-8628(19990604)84:4&#x0003c;311::AID-AJMG1&#x0003e;3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  • 58.Breugem CC, Mink van der Molen AB. What is ‘Pierre Robin sequence’? J Plast Reconstr Aesthet Surg. 2009;62:1555–1558. doi: 10.1016/j.bjps.2008.06.050. [DOI] [PubMed] [Google Scholar]
  • 59.Breugem CC, Courtemanche DJ. Robin sequence: clearing nosologic confusion. Cleft Palate Craniofac J. 2010;47:197–200. doi: 10.1597/08-061.1. [DOI] [PubMed] [Google Scholar]
  • 60.Marques IL, Prado-Oliveira R, Leiriao VH, et al. Clinical and fiberoptic endoscopic evaluation of swallowing in robin sequence treated with nasopharyngeal intubation: the importance of feeding facilitating techniques. Cleft Palate Craniofac J. 2010;47:523–529. doi: 10.1597/09-002. [DOI] [PubMed] [Google Scholar]
  • 61.Maas C, Poets CF. Initial treatment and early weight gain of children with Robin sequence in Germany: a prospective epidemiological study. Arch Dis Child Fetal Neonatal Ed. 2014;99:F491–F494. doi: 10.1136/archdischild-2014-306472. [DOI] [PubMed] [Google Scholar]
  • 62.Meyer AC, Lidsky ME, Sampson DE, et al. Airway interventions in children with Pierre Robin sequence. Otolaryngol Head Neck Surg. 2008;138:782–787. doi: 10.1016/j.otohns.2008.03.002. [DOI] [PubMed] [Google Scholar]
  • 63.Myer CM, 3rd, Reed JM, Cotton RT, et al. Airway management in Pierre Robin sequence. Otolaryngol Head Neck Surg. 1998;118:630–635. doi: 10.1177/019459989811800511. [DOI] [PubMed] [Google Scholar]
  • 64.Kirschner RE, Low DW, Randall P, et al. Surgical airway management in Pierre Robin sequence: is there a role for tongue–lip adhesion? Cleft Palate Craniofac J. 2003;40:13–18. doi: 10.1597/1545-1569(2003)040&#x0003c;0013:SAMIPR&#x0003e;2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 65.Papoff P, Guelfi G, Cicchetti R, et al. Outcomes after tongue–lip adhesion or mandibular distraction osteogenesis in infants with Pierre Robin sequence and severe airway obstruction. Int J Oral Maxillofac Surg. 2013;42:1418–1423. doi: 10.1016/j.ijom.2013.07.747. [DOI] [PubMed] [Google Scholar]
  • 66.Paes EC, Mink van der Molen AB, Muradin MS, et al. A systematic review on the outcome of mandibular distraction osteogenesis in infants suffering Robin sequence. Clin Oral Investig. 2013;17:1807–1820. doi: 10.1007/s00784-013-0998-z. [DOI] [PubMed] [Google Scholar]
  • 67.Rogers GF, Murthy AS, LaBrie RA, et al. The GILLS score: part I. Patient selection for tongue-lip adhesion in Robin sequence. Plast Reconstr Surg. 2011;128:243–251. doi: 10.1097/PRS.0b013e318217420d. [DOI] [PubMed] [Google Scholar]
  • 68.Rogers GF, Lim AA, Mulliken JB, et al. Effect of a syndromic diagnosis on mandibular size and sagittal position in Robin sequence. J Oral Maxillofac Surg. 2009;67:2323–2331. doi: 10.1016/j.joms.2009.06.010. [DOI] [PubMed] [Google Scholar]
  • 69.Murage KP, Tholpady SS, Friel M, et al. Outcomes analysis of mandibular distraction osteogenesis for the treatment of Pierre Robin sequence. Plast Reconstr Surg. 2013;132:419–421. doi: 10.1097/PRS.0b013e3182958a54. [DOI] [PubMed] [Google Scholar]
  • 70.Abramowicz S, Bacic JD, Mulliken JB, et al. Validation of the GILLS score for tongue-lip adhesion in Robin sequence patients. J Craniofac Surg. 2012;23:382–386. doi: 10.1097/SCS.0b013e318240fc7b. [DOI] [PubMed] [Google Scholar]
  • 71.Hong P, Brake MK, Cavanagh JP, et al. Feeding and mandibular distraction osteogenesis in children with Pierre Robin sequence: a case series of functional outcomes. Int J Pediatr Otorhinolaryngol. 2012;76:414–418. doi: 10.1016/j.ijporl.2011.12.023. [DOI] [PubMed] [Google Scholar]
  • 72.Hong P, McNeil M, Kearns DB, et al. Mandibular distraction osteogenesis in children with Pierre Robin sequence: impact on health-related quality of life. Int J Pediatr Otorhinolaryngol. 2012;76:1159–1163. doi: 10.1016/j.ijporl.2012.04.025. [DOI] [PubMed] [Google Scholar]
  • 73.Paes EC, Fouche JJ, Muradin MS, et al. Tracheostomy versus mandibular distraction osteogenesis in infants with Robin sequence: a comparative cost analysis. Br J Oral Maxillofac Surg. 2014;52:223–229. doi: 10.1016/j.bjoms.2013.11.017. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Oral Investigations are provided here courtesy of Springer

RESOURCES